Virgo Uap Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.25 M
as on 16-11-2024
- Paid Up Capital ₹ 6.23 M
as on 16-11-2024
- Company Age 27 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.42 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-11-2024
- Revenue 33.65%
(FY 2023)
- Profit 69.17%
(FY 2023)
- Ebitda 31.58%
(FY 2023)
- Net Worth 21.33%
(FY 2023)
- Total Assets 13.75%
(FY 2023)
About Virgo Uap Pharma
The Corporate was formerly known as Virgo Remedies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.25 M and a paid-up capital of Rs 6.23 M.
The company currently has active open charges totaling ₹4.42 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajulaben Shah, Darshan Shah, and Alkaben Shah serve as directors at the Company.
- CIN/LLPIN
U24230GJ1997PTC033375
- Company No.
033375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationAhmedabad, Gujarat
- Telephone
- Email Address
- Website
- Social Media
What products or services does Virgo Uap Pharma Private Limited offer?
Virgo Uap Pharma Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Carrier Oil, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic Churna and Goli, Ayurvedic Herbal Syrups & Tonics, Herbal Oil, Common Disease Medicines.
Who are the key members and board of directors at Virgo Uap Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajulaben Shah  | Director | 28-Jul-2021 | Current |
| Darshan Shah | Director | 02-Dec-1997 | Current |
| Alkaben Shah | Director | 28-Jul-2021 | Current |
Financial Performance of Virgo Uap Pharma.
Virgo Uap Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.65% increase. The company also saw a substantial improvement in profitability, with a 69.17% increase in profit. The company's net worth Soared by an impressive increase of 21.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Virgo Uap Pharma?
In 2023, Virgo Uap Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Virgo Welltrade Private LimitedActive 5 years 3 monthsRajulaben Shah, Darshan Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2023 | ₹2.50 M | Open |
Hdfc Bank Limited Creation Date: 27 Jul 2016 | ₹4.17 Cr | Open |
Oriental Bank Of Commerce Creation Date: 02 May 2012 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Virgo Uap Pharma?
Virgo Uap Pharma has a workforce of 142 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Virgo Uap Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virgo Uap Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
